Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 17

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments

Rademacher, Christoph, Landström, Jens, Sindhuwinata, Nora, Palcic, Monica M., Widmalm, Göran, Peters, Thomas · 2010 · Glycoconjugate Journal

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10719-010-9282-5

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 37

  1. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E. (eds.): Essentials of glycobiology. Cold Spring Harbor Laboratory, New York (2009)
  2. Brown, J.R., Fuster, M.M., Li, R., Varki, N., Glass, C.A., Esko, J.D.: A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin. Cancer Res. 12, 2894–2901 (2006) · DOI
  3. Kannagi, R.: Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj. J. 20, 353–364 (2004) · DOI
  4. Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., Kimura, N.: Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 95, 377–384 (2004) · DOI · Paper page
  5. Mathew, B., Schmidt, R.R.: Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings. Carbohydr. Res. 342, 558–566 (2007) · doi:10.1016/j.carres.2006.08.016
  6. Palcic, M.M., Heerze, L.D., Srivastava, O.P., Hindsgaul, O.: A bisubstrate analog inhibitor for alpha(1–2)-fucosyltransferase. J. Biol. Chem. 264, 17174–17181 (1989) · DOI
  7. Jung, K.H., Schmidt, R.R.: Glycosyltransferase inhibitors. In: Wong, C.-H. (ed.) Carbohydrate-based drug discovery, pp. 609–659. Wiley-VCH, Weinheim (2003) · doi:10.1002/3527602437.ch23
  8. Hamilton, S.R., Gerngross, T.U.: Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr. Opin. Biotechnol. 18, 387–392 (2007) · DOI · Paper page
  9. Muller, B., Schaub, C., Schmidt, R.R.: Efficient sialyltransferase inhibitors based on transition-state analogues of the sialyl donor. Angew. Chem. Int. Edit. 37, 2893–2897 (1998) · DOI
  10. Schaub, C., Muller, B., Schmidt, R.R.: New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay. Glycoconj. J. 15, 345–354 (1998) · DOI
  11. Skropeta, D., Schworer, R., Haag, T., Schmidt, R.R.: Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues. Glycoconj. J. 21, 205–219 (2004) · doi:10.1023/b:glyc.0000045093.96413.62
  12. Izumi, M., Yuasa, H., Hashimoto, H.: Bisubstrate analogues as glycosyltransferase inhibitors. Curr. Top Med. Chem. 9, 87–105 (2009) · doi:10.2174/156802609787354351
  13. Izumi, M., Kaneko, S., Yuasa, H., Hashimoto, H.: Synthesis of bisubstrate analogues targeting alpha-1, 3-fucosyltransferase and their activities. Org. Biomol. Chem. 4, 681–690 (2006) · doi:10.1039/b513897c
  14. Yazer, M.H., Olsson, M.L., Palcic, M.M.: The cis-AB blood group phenotype: fundamental lessons in glycobiology. Transfus. Med. Rev. 20, 207–217 (2006) · DOI
  15. Mayer, M., Meyer, B.: Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38, 1784–1788 (1999) · DOI · Paper page
  16. Scherf, T., Anglister, J.: A T1 rho-filtered two-dimensional transferred NOE spectrum for studying antibody interactions with peptide antigens. Biophys. J. 64, 754–761 (1993) · doi:10.1016/s0006-3495(93)81436-x
  17. Jahnke, W., Rudisser, S., Zurini, M.: Spin label enhanced NMR screening. J. Am. Chem. Soc. 123, 3149–3150 (2001) · DOI
  18. Meyer, B., Peters, T.: NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew. Chem. Int. Ed. Engl. 42, 864–890 (2003) · DOI · Paper page
  19. Ludwig, C., Guenther, U.L.: Ligand based NMR methods for drug discovery. Front. Biosci. 14, 4565–4574 (2009) · DOI
  20. Diercks, T., Coles, M., Kessler, H.: Applications of NMR in drug discovery. Curr. Opin. Chem. Biol. 5, 285–291 (2001) · DOI
  21. Coles, M., Heller, M., Kessler, H.: NMR-based screening technologies. Drug. Discov. Today 8, 803–810 (2003) · doi:10.1016/s1359-6446(03)02796-x
  22. Pellecchia, M., Bertini, I., Cowburn, D., Dalvit, C., Giralt, E., Jahnke, W., James, T.L., Homans, S.W., Kessler, H., Luchinat, C., Meyer, B., Oschkinat, H., Peng, J., Schwalbe, H., Siegal, G.: Perspectives on NMR in drug discovery: a technique comes of age. Nat. Rev. Drug Discov. 7, 738–745 (2008) · DOI · Paper page
  23. Wyss, D.F., McCoy, M.A., Senior, M.M.: NMR-based approaches for lead discovery. Curr. Opin. Drug Discov. Devel. 5, 630–647 (2002)
  24. Marcus, S.L., Polakowski, R., Seto, N.O., Leinala, E., Borisova, S., Blancher, A., Roubinet, F., Evans, S.V., Palcic, M.M.: A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase. J. Biol. Chem. 278, 12403–12405 (2003) · DOI · Paper page
  25. Hwang, T.L., Shaka, A.J.: Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112, 275–279 (1995) · DOI · Paper page
  26. Sindhuwinata, N., Miunoz, E., Munoz, F.J., Palcic, M.M., Peters, H., Peters, T.: Binding of an acceptor substrate analog enhances the enzymatic activity of human blood group B galactosyltransferase. Glycobiology. in press. · DOI · Paper page
  27. Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J.: AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. (2009) · DOI · Paper page
  28. Blume, A., Angulo, J., Biet, T., Peters, H., Benie, A.J., Palcic, M., Peters, T.: Fragment-based screening of the donor substrate specificity of human blood group B galactosyltransferase using saturation transfer difference NMR. J. Biol. Chem. 281, 32728–32740 (2006) · DOI · Paper page
  29. Shoemaker, G.K., Soya, N., Palcic, M.M., Klassen, J.S.: Temperature-dependent cooperativity in donor-acceptor substrate binding to the human blood group glycosyltransferases. Glycobiology 18, 587–592 (2008) · DOI
  30. Stockman, B.J., Dalvit, C.: NMR screening techniques in drug discovery and drug design. Prog. Nucl. Magn. Reson. Spectrosc. 41, 187–231 (2002) · DOI · Paper page
  31. Dalvit, C., Flocco, M., Knapp, S., Mostardini, M., Perego, R., Stockman, B.J., Veronesi, M., Varasi, M.: High-throughput NMR-based screening with competition binding experiments. J. Am. Chem. Soc. 124, 7702–7709 (2002) · DOI
  32. Manzenrieder, F., Frank, A.O., Kessler, H.: Phosphorus NMR spectroscopy as a versatile tool for compound library screening. Angew. Chem. Int. Ed. Engl. 47, 2608–2611 (2008) · DOI
  33. Klages, J., Coles, M., Kessler, H.: NMR-based screening: a powerful tool in fragment-based drug discovery. Analyst 132, 693–705 (2007) · DOI
  34. Leone, M., Freeze, H.H., Chan, C.S., Pellecchia, M.: The Nuclear overhauser effect in the lead identification process. Curr. Drug. Discov. Technol. 3, 91–100 (2006) · doi:10.2174/157016306778108884
  35. Sem, D.S., Pellecchia, M.: NMR in the acceleration of drug discovery. Curr. Opin. Drug Discov. Devel. 4, 479–492 (2001)
  36. Schuffenhauer, A., Ruedisser, S., Marzinzik, A.L., Jahnke, W., Blommers, M., Selzer, P., Jacoby, E.: Library design for fragment based screening. Curr. Top Med. Chem. 5, 751–762 (2005) · DOI · Paper page
  37. Rudisser, S., Jahnke, W.: NMR and in silico screening. Comb. Chem. High Throughput Screen 5, 591–603 (2002) · doi:10.2174/1386207023329987

Cited by

See all 17

Metadata

Authors
Rademacher, C., Landström, J., Sindhuwinata, N., Palcic, M. M., Widmalm, G., & Peters, T.
Venue
Glycoconjugate Journal
Published
2010-03-09
Volume
27
Issue
3
Pages
349-358
ISSN
  • 0282-0080
  • 1573-4986
Cited by
17
References
2
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments. https://app.cochat.ai/papers/10.1007/s10719-010-9282-5
The paper
Rademacher, C., Landström, J., Sindhuwinata, N., Palcic, M. M., Widmalm, G., & Peters, T. (2010). NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments. Glycoconjugate Journal. https://doi.org/10.1007/s10719-010-9282-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.